Sections

1. Investment Snapshot

2. Price Chart

3. Thesis

4. Valuation & Price Target

5. Business & Product Moat

6. People & Governance

7. Risk Register

Discussion

Inline comments

Investment Snapshot

Price Chart

Thesis

Valuation & Price Target

Business & Product Moat

People & Governance

Risk Register

Discussion

GMR Solutions Inc.

Analyst research, target price, syndicate analytics, and valuation sections are included with an active subscription. View plans

Investment Snapshot

424B4 All Filings

Symbol

GMRS

IPO Date (Actual)

2026-05-13

Offer Range

$15.00

Shares Offered

31.9M

Total Shares Post-IPO

239.2M

Market Cap

—

Target Price

$00.00

Implied Upside vs Midpoint

$00.00

Use of Proceeds

Estimated gross proceeds at midpoint ~$750.0M; net proceeds to company ~ $669.2M (midpoint). Stated uses: (i) $299,325,258 to redeem certain Series B Preferred Stock and (ii) remaining proceeds (plus other cash/private placement proceeds) to repay a portion of $770.0M outstanding borrowings under the 2032 First Lien Term Loan (per SEC S‑1).

Price Chart

Historic Price Chart - GMRS

DividendsSplits/Mergers

Thesis

GMR Solutions Inc. (proposed ticker GMRS) is a U.S. emergency medical services (EMS) and out‑of‑hospital care provider operating in roughly 1,400 U.S. counties with ~34,000 employees (~24,000 clinicians). The company generates most revenue from emergent and non‑emergent patient transports and long‑term contract preferred‑provider arrangements with dispatchers, hospitals and other requesting entities. Financially, FY2025 LTM revenue was $5.740B with operating income of $751.6M (13.1 operating margin) and net income of $206.2M; the company reported a 2024→2025 revenue decline of -3.96 in its SEC Form S‑1.

Valuation & Price Target

████████████████████

Business & Product Moat

████████████████████

Company Description (Source)

We are the largest provider of emergency medical services (“EMS”) and one of the largest integrated providers of essential alternate-site, out-of-hospital care in the United States, and are one of the largest mobile clinical practice groups globally. We care for patients when they need us most — whether at home, at the site of an accident, while attending an event or in other settings where time-sensitive care is needed. As the entry point for patients into the healthcare system, we deploy our expertly trained and credentialed clinical teams to provide on-site care, and if necessary, transport patients to the most appropriate healthcare facility, or, if the patient is non-emergent, navigate the patient to a less acute setting. As the only national, fully-integrated air and ground EMS provider, our operations span approximately 1,400 U.S. counties, covering both rural and urban communities which are home to more than 60% of the U.S. population as of December 31, 2025. We are at the front line of the healthcare continuum, encountering approximately 15,000 patients per day or approximately 5.5 million patients annually and our clinicians perform a critical care intervention every 89 seconds. Because of our scale, we have a data set of more than 80 million patient care records, which we use to track care processes and patient outcomes, and identify the most effective methods for patient care. Our team of more than 24,000 clinicians serves as the first line of care, providing lifesaving treatment at crucial moments. We maintain longstanding relationships across the healthcare ecosystem, serving local communities, health systems, payors, public health and local, state and federal agencies. We believe that our robust scale, relationships, and clinical, operational and logistical capabilities make us a leader in essential alternate-site, out-of-hospital care. We are a critical community and disaster safety net, providing essential EMS across the nation, responding to approximately 10% of all 911 calls and 37% of emergent air medical calls nationwide as of December 31, 2025. As the healthcare landscape continues to evolve — driven by rural hospital closures, provider shortages, an aging population, and growing strain on existing infrastructure — our role in providing care and critical support to a growing number of patients in need continues to be increasingly vital. In rural communities, we are often the sole access point for lifesaving care. To meet this growing need, we have developed a comprehensive and fully integrated set of solutions for both emergent and non-emergent care, where our clinicians manage patients across a wide range of acuity levels, distances and transport modalities. Our Emergent Care services are defined by rapid, clinically appropriate responses, lifesaving critical interventions and, when necessary, transport to the next site of care. Our Non-emergent Care services include scheduled, non-emergency patient care. In 2025, Emergent Care accounted for approximately 84% of our patient encounters, and Non-emergent Care represented approximately 16%. Moreover, since our 2018 merger of Air Medical Group Holdings LLC (“AMGH”), the leading air ambulance provider, with AMR, the leading ground ambulance provider (the “AMR Merger”), we have been able to further integrate air ambulance and ground ambulance with our advanced care navigation and technology solutions. By integrating these capabilities, we are better able to meet the patient’s needs by delivering more coordinated and efficient care. Clinicians, including emergency medical technicians (“EMTs”), paramedics and nurses, comprise almost three quarters of our approximately 34,000 team members. Together with our professional pilots, mechanics, communications specialists and other operational support roles, we deliver comprehensive care across a wide range of time-sensitive patient conditions, from cardiac arrests, strokes and significant traumatic injuries, to acute behavioral health episodes, toxic exposures, drug overdoses and even emergent in-the-field newborn deliveries. In fiscal year 2025, we had approximately 15,000 daily patient encounters (based on 5,473,675 for the year), which comprised, among other things, approximately 117 cardiac arrest responses (based on 42,863 for the year), 138 emergency stroke patients (based on 50,340 for the year), 114 critically injured trauma patient transports (based on 41,683 for the year), 642 blood glucose assessments on patients with altered mental status (based on 234,484 for the year), 113 critical airway interventions (based on 41,105 for the year) and 2,260 intravenous access (based on 824,770 for the year). Our care is guided by consensus-based patient care guidelines, which we have developed collaboratively with nearly 200 affiliated physician partners specializing in emergency medicine, pediatric and neonatal care, critical care, trauma surgery, acute cardiology, neuroscience and infectious disease. As the largest EMS provider in the country, we engage in specialty research projects focused on care delivery and partner with academic centers to scientifically explore more effective methods for patient care. These projects are reviewed by external peer publications and published to guide and improve care. We believe that the breadth and depth of our clinical practices and team set the industry-wide standard for alternate-site care delivery. We support governments, communities, health systems and payors who choose us to serve their patients because of our long and proven track record of clinical performance, capabilities, innovative offerings, broad geographic footprint and unmatched fleet. While we face intense competition, we believe our ability to rapidly deploy specialized resources and personnel to acute and rapidly evolving situations has established us as the provider of choice for large scale, unplanned events and incidents. Our clinicians utilize our approximately 7,400 ground ambulances and vehicles, as well as 400 rotor-wing and 113 fixed-wing air ambulances, operating from more than 780 physical locations across 45 states, as of December 31, 2025. These air and ground ambulances are dispatched from our 48 communication centers and are able to provide service to all 50 states. Combined with our extensive operational experience, this infrastructure allows us to deliver tailored care for large and small 911 systems, scaled multi-facility health systems, large events and respond to critical natural and other disasters. In situations that require significant investment and a rapid scaling of clinical and physical resources, we believe our relationships across critical supply chains, our logistical expertise and our financial resources enhance our ability to secure and execute large, complex contracts. For example, in one of our partnerships, we provide emergent, non-emergent and event medical care and transportation to over 2,500 patients per week, with a peak deployment of over 100 ambulances and aircraft, covering over 7,200 square miles to support nearly 2.5 million people. We continuously innovate new first-in-class or only-in-class solutions to solve the longstanding and evolving challenges our stakeholders face. Today, we participate in nearly 20 active EMS research programs with leading academic medical centers to advance the management of time-sensitive alternate-site care. Our differentiated collaborations with industry partners provide real-world insights that shape emerging technology and clinical decision support tools. We developed, pioneered and are deploying our Nurse Navigation clinical protocol and screening process to transform 911 intake by guiding patients to the most appropriate site-of-care, with the objective of improving resource utilization and reducing costs for patients, payors, providers and communities. As of December 31, 2025, our Nurse Navigation had access to over 19 million covered lives resulting in up to 20% of low acuity 911 calls navigated to other care settings. We designed and developed our proprietary online request platform, Transport.Net, which encompasses a suite of digital tracking and dispatch solutions for both air and ground ambulance requests. The modules within Transport.Net are tailored to the unique needs of our customers and were designed to seamlessly integrate with existing technologies, such as a hospital’s Electronic Health Record (“EHR”). Our RapidCall module is used by approximately 50% of all 911 access points and health systems to provide greater visibility, streamline access to requesting ambulances, reduce response times and enhance operational efficiency when deploying emergent resources. Additionally, our Concierge module enables health systems to control their discharge process by scheduling advance transports and freeing up beds, leading to an up to 0.5 day reduction in length of stay in certain locations. We believe our scale, breadth and clinical depth enable us to develop innovations which enhance the value and care delivered to our stakeholders. We have a demonstrated track record of delivering strong revenue and earnings growth through organic volume growth, market share gains, productivity improvements and strategic contracting. Through our managed care contracting strategy, we develop preferred relationships with payors. We are primarily a fee-for-service provider, which represents approximately 90% of our revenue. Additionally, our service diversification and wide geographic coverage helps to minimize revenue variability and support financial stability. We are highly diversified, with limited revenue concentration across more than 650 commercial payors and 600 operating locations. We actively manage our business on a market-to-market basis, continually assessing contracted rates, cost structure, and profitability to optimize performance and identify new growth opportunities. In early 2025, we completed a strategic review of our business, concluding a multi-year process in which we exited select underperforming contracts to re-focus on our core operations and drive growth and profitability. Additionally, in the fourth quarter of 2024, we completed the divestitures of three non-core businesses. Our leadership team brings deep expertise across operations, clinical excellence, finance and logistics, which we believe positions us to continue to grow and strengthen our business. --- Our principal executive offices are located at 4400 Hwy 121, Suite 700, Lewisville, TX 75056. Our telephone number is (972) 459-4919. We maintain a website at globalmedicalresponse.com.

Competitor Set

████████████████████

People & Governance

Nick Loporcaro

Chairman & CEO

Strengths

CEO since April 2023; former Senior Operating Partner at The Vistria Group; ex‑CEO of Landmark Health; ~16 years in senior leadership roles at McKesson. His background is squarely in large healthcare services and roll‑up operating environments, giving direct operational experience relevant to a national EMS and out‑of‑hospital platform. Red flags / negatives: No litigation, SEC enforcement actions, criminal convictions or regulatory sanctions involving Mr. Loporcaro were disclosed in the provided S‑1 extract or in the search snippets supplied; biography disclosure in the provided extract is limited (additional background detail should be checked in the full S‑1 for any compensation arrangements, related‑party transactions, or prior business outcomes). Overall: demonstrable sector operating experience but limited adverse‑action disclosure in the dataset (no red flags found in the supplied material).

Edward Van Horne

President & COO

Strengths

President and COO since April 2019 (per S‑1); prior CEO President roles at AMR (American Medical Response); began career as an EMT — long operational EMS experience and frontline clinical background that supports operational leadership of transport services. Red flags / negatives: No adverse legal regulatory matters were disclosed in the provided S‑1 extract; the supplied dataset offers no information on any failed ventures or regulatory issues but full background checks and S‑1 biographies should be reviewed for completeness. Overall: strong, operational EMS credentials with practical field and executive experience; no negative items identified in the provided documents.

Brian Tierney

Executive Vice President & CFO

Strengths

CFO since August 2023; ~15 years with GMR and predecessor companies in finance and accounting roles providing continuity of accounting and operational finance knowledge; prior finance roles at American Airlines per the S‑1. Red flags / negatives: No litigation, regulatory or SEC enforcement actions disclosed in the supplied S‑1 extract; the S‑1 extract does not include more detailed track record (e.g., prior public company financial reporting issues) so additional diligence is recommended. Overall: internal continuity and company‑specific finance experience are positives; no red flags found in the provided material.

Thomas Cook

Executive Vice President, General Counsel & Secretary

Strengths

General Counsel and Chief Compliance Officer since 2015, EVP roles since 2018 — in‑house legal and compliance experience at the company level, indicating familiarity with regulatory, contractual and transactional matters. Red flags / negatives: No legal regulatory issues or sanctions involving Mr. Cook were identified in the supplied S‑1 extract or search snippets; the provided dataset contains only limited public detail beyond the S‑1 disclosure. Overall: experienced in‑house counsel with compliance responsibilities; no adverse items disclosed in the provided materials.

Lisa Jacoba

Executive Vice President & Chief Human Resources Officer

Strengths

Listed as EVP and CHRO in the S‑1, indicating senior HR leadership responsibility for a large national workforce (~34,000 employees). Red flags / negatives: The AI‑extracted filing text supplied did not include prior roles, education or other biographical detail for Ms. Jacoba; no adverse legal regulatory matters were disclosed in the extract. Overall: role fits the company’s operational needs, but publicly available biography in the supplied dataset is limited — obtain the full S‑1 bio for assessment of HR track record and any employment‑related controversies.

Johnny Kim

Director

Strengths

Named as a director in the S‑1. Detailed biography and credentials were not included in the AI‑extracted dataset supplied; the full S‑1 likely contains prior roles and education. Red flags / negatives: No adverse legal regulatory matters or red flags were found in the provided search snippets; however, absence of detail in the supplied extract means additional review of the full S‑1 and external background checks is advised. Overall: director nominee with unknown public track record in the supplied data.

Max Lin

Director

Strengths

Listed as a director in the S‑1 filing. The supplied extract did not include his full biography or prior roles education. Red flags / negatives: No legal regulatory issues were disclosed in the provided dataset. Overall: insufficient public detail in the supplied extract to fully evaluate; consult the full S‑1 for a complete background and any related‑party disclosures.

Jan Stern Reed

Director nominee

Strengths

Listed as a director nominee in the S‑1. The S‑1 extract supplied contained limited biographical detail. Red flags / negatives: No adverse matters were found in the provided snippets; additional S‑1 review recommended. Overall: director nominee — full S‑1 biography needed to assess experience and any valuation‑relevant red flags.

Timothy Wicks

Director nominee

Strengths

Listed as a director nominee in the S‑1. The AI‑extracted dataset offered limited background. Red flags / negatives: No negative items identified in the provided material; further due diligence via the full S‑1 and public records is recommended. Overall: limited supplied information prevents a full judgment.

Risk Register

Revenue/volume risk: the majority of revenue depends on patient transport volumes; FY2025 LTM revenue declined -3.96 YoY (2024→2025), exposing revenue and margin to volume shocks (SEC S‑1 Risk Factors).

High leverage and interest burden: significant outstanding borrowings (including a referenced $770.0M 2032 first‑lien term loan) that the company plans to repay with IPO proceeds — until repayment, leverage and interest expense are material risks to cash flow and free cash generation.

Operational fixed‑cost structure: high fixed costs tied to personnel, vehicles aircraft and insurance create operating leverage that can rapidly depress margins if volumes fall or payor reimbursement worsens (SEC S‑1 Risk Factors).